Albemarle Corp's Net Loss has experienced a moving upward cycle characterized by stable volatility. Compared with the previous period, Net Loss is up roughly 5.26%, supporting projections near approximately -643.5 M. Net Loss is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
Analyzing Albemarle Corp's Net Income Applicable To Common Shares over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income Applicable To Common Shares has evolved provides context for assessing Albemarle Corp's current valuation and future prospects.
Latest Albemarle Corp's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Albemarle Corp over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Albemarle Corp's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Albemarle Corp's overall financial position and show how it may be relating to other accounts over time.
Albemarle Net Income Applicable To Common Shares Regression Statistics
Arithmetic Mean
340,120,288
Coefficient Of Variation
257.65
Mean Deviation
545,648,199
Median
334,906,000
Standard Deviation
876,319,652
Sample Variance
767936.1T
Range
4B
R-Value
-0.12
Mean Square Error
808179T
R-Squared
0.01
Significance
0.66
Slope
-20,066,911
Total Sum of Squares
12286978.1T
Albemarle Net Income Applicable To Common Shares History
2026
-643.5 M
2025
-677.4 M
2024
-1.3 B
2023
1.6 B
2022
2.7 B
2021
123.7 M
2020
375.8 M
Stock Overview, Methodology & Data Sources
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina. Albemarle Corp operates under Specialty Chemicals classification in the United States and is traded on New York Stock Exchange. It employs 6000 people. This overview emphasizes how Albemarle Corp compares to peers on valuation quality and operating consistency. Current metrics include P/E of 21.52, P/B of 2.55, profit margin of -9.93%. Albemarle Corp has a market cap of 18.65 B, P/E of 21.52, ROE of -4.66%.
Methodology
Unless otherwise specified, financial data for Albemarle Corp is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Albemarle (USA Stocks:ALB) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Underlying inputs rely on public filings and market reference sources, including disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR. Values may reflect publication timing differences. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Albemarle Corp has active sell-side coverage. Source-validated coverage currently shows 25 approved analysts, while broader market-consensus totals may differ across providers due to methodology and update timing. 12 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Bernstein Research, Deutsche Bank, Morgan Stanley, BMO Capital Markets, Guggenheim Securities, Jefferies, Goldman Sachs, Evercore ISI, Raymond James, UBS Investment Research, among others. Updates may occur throughout the day.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
A comprehensive view of Albemarle Corp starts with financial statements and ratio context. Ratios and trend metrics help frame Albemarle Corp's operating context across reporting periods. Key reports that frame Albemarle Corp Stock are listed below:
Albemarle Corp Correlation provides competitor comparison context for Albemarle Corp. This supports competitive context.
Our How to Invest in Albemarle Corp guide provides practical guidance on trading Albemarle Stock.Albemarle Corp P/E of 21.52 alongside ROE at -4.66% frames the starting point - the resources below add portfolio-level context that single-security analysis cannot provide alone. Those return and profitability levels shape the investment picture - the supplemental tools help investors decide if they are sustainable. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Quarterly Earnings Growth
-0.66
Dividend Share
1.62
Earnings Share
-5.76
Revenue Per Share
43.707
Quarterly Revenue Growth
0.159
Albemarle Corp's market price can diverge from book value, the accounting figure shown on Albemarle's balance sheet. Albemarle Corp's market capitalization is 18.65 B. Albemarle Corp P/B of 2.55 shows the market assigns a modest premium over accounting equity. Enterprise value stands at 22.56 B. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
The concept of value for Albemarle Corp differs from its quoted price, since each reflects a different lens. For Albemarle Corp, key inputs include a P/E ratio of 21.52, a P/B ratio of 2.55, a profit margin of -9.93%, and ROE of -4.66%. Albemarle Corp's trading price represents the transaction level agreed by market participants.